Core interpretation
The findings point to a
Jarisch–Herxheimer reaction (JHR). Within
24 hours after the first dose of an effective antisyphilitic antibiotic, the woman develops
fever 38.3 °C, headache, and muscle aches. Her blood pressure is stable at
118/76 mmHg, and there is no wheezing, urticaria, or angioedema.
This pattern is most consistent with a systemic reaction to substances released by dying spirochetes, not with anaphylaxis or local infection.
Why this is JHR, not anaphylaxis
JHR is a transient, self-limited systemic response that follows the first dose of an effective antisyphilitic agent
[2]. It is triggered when
Treponema pallidum organisms are rapidly killed, releasing
lipoproteins, cytokines, and endotoxin-like mediators. The resulting inflammatory cascade produces fever, chills, headache, myalgia, and sometimes worsening of existing syphilitic lesions
[1][4]. The reaction typically begins within
1 to 24 hours after treatment
[4].
Anaphylaxis, by contrast, is an
IgE-mediated type I hypersensitivity reaction. It presents with rapid-onset bronchospasm, laryngeal edema, hypotension, urticaria, and cardiovascular collapse.
The absence of wheezing, hives, lip swelling, and hypotension makes anaphylaxis unlikely in this patient. A normal blood pressure of
118/76 mmHg further argues against a severe systemic allergic reaction.
Clinical course and management
JHR is expected and self-limiting. It does not indicate treatment failure, and it is not a reason to stop or repeat penicillin. Management is supportive: antipyretics such as acetaminophen, reassurance, and monitoring. The symptoms usually resolve within
12 to 24 hours without specific intervention
[2][4].
Watch out! JHR can be mistaken for penicillin allergy. A patient who develops fever and myalgia after the first penicillin dose may be incorrectly labeled allergic. In syphilis care, this distinction matters because penicillin remains the treatment of choice, and unnecessary avoidance can compromise cure
[2].
Key point! JHR is more common when syphilis is treated in its
early stages, when the spirochete burden is high . Secondary syphilis, as in this case, is an early stage and carries a higher likelihood of JHR than late latent or tertiary disease.
Differential summary
| Finding | Jarisch–Herxheimer reaction | Anaphylaxis | Treatment failure | Injection-site abscess |
|---|
| Onset | 1–24 hours after first dose | Minutes to 1 hour | Days to weeks | Days |
| Fever, headache, myalgia | Common | Possible but with other signs | Possible if infection progresses | Fever possible, local pain dominant |
| Wheezing, hives, lip swelling | Absent | Present | Absent | Absent |
| Blood pressure | Normal or slightly elevated | Often low | Normal | Normal |
| Local injection site | No specific local finding | No specific local finding | No specific local finding | Erythema, warmth, induration |
| Management | Antipyretics, observe | Epinephrine, airway support | Repeat or extend treatment | Incision and drainage, antibiotics |
Nursing implications for the RHU setting
In a rural health unit, the nurse should anticipate JHR in any patient receiving the first dose of benzathine penicillin G for early syphilis. Before injection, explain that a brief flu-like reaction may occur and is not an allergy. After injection, observe for at least
30 minutes for immediate hypersensitivity, but also advise the patient to report fever, headache, or muscle aches within the next day.
The key nursing action is to recognize JHR as an expected, self-limited response and treat symptoms with antipyretics rather than withholding future penicillin doses.References (research sources)
- [1]
Jarisch-Herxheimer reaction as a complication of penicillin G and ceftriaxone treatment in neurosyphilis.Research articleFeng X, Yu J, Gu X, Yang Y, Jiang N, Wang G, Zou D, Ye M, Zhou P. (2026) · DOI: 10.1186/s12879-026-12683-2
- [2]
Jarisch-Herxheimer reaction in syphilis.Research articleNair BR, Murugan S (2022) · DOI: 10.4103/ijstd.ijstd_3_22
- [4]
Penicillin-induced Jarisch-Herxheimer reaction.Research articleSee S, Scott EK, Levin MW (2005) · DOI: 10.1345/aph.1G308